Andover, MA, United States of America

Ishan Sanjeev Shah

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Voyager Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ishan Sanjeev Shah. Retrieved from https://idiyas.com/inventor/ishan-sanjeev-shah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ishan Sanjeev Shah: Innovator in Neurological Treatments

Introduction

Ishan Sanjeev Shah is a prominent inventor based in Andover, MA (US). He has made significant contributions to the field of neurology through his innovative research and development of therapeutic solutions. His work focuses on addressing neurological indications, which are critical for improving patient outcomes.

Latest Patents

Ishan holds a patent for "Tau binding compounds." This patent provides anti-tau antibodies and their vectorization into AAV particles. The methods outlined in this patent are aimed at the prevention, treatment, and diagnosis of various neurological conditions. His innovative approach has the potential to transform the landscape of neurological therapies.

Career Highlights

Ishan is currently employed at Voyager Therapeutics, Inc., where he continues to advance his research in neurological treatments. His work at Voyager Therapeutics has positioned him as a key player in the development of novel therapies that target tau-related diseases.

Collaborations

Ishan collaborates with notable colleagues, including Wencheng Liu and Todd Carter. These partnerships enhance the research efforts at Voyager Therapeutics and contribute to the advancement of innovative solutions in neurology.

Conclusion

Ishan Sanjeev Shah is a dedicated inventor whose work in developing tau binding compounds is paving the way for new treatments in neurology. His contributions are vital for the future of neurological health and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…